Foregene Co., Ltd.: A Leading Provider of Innovative Molecular Biology Lab Reagents and IVD Kits
Foregene Co., Ltd. is a leading provider of innovative molecular biology lab reagents and IVD kits. The company is specialized in providing highly accurate and reliable solutions for a wide range of applications in molecular biology, including PCR (polymerase chain reaction), IHC (immunohistochemistry), FISH (fluorescence in situ hybridization), and NGS (next-generation sequencing).
Foregene is integrated in R&D (research and development), production, and marketing. The company has a team of highly experienced professionals who are dedicated to developing cutting-edge solutions that meet the needs of researchers and clinicians worldwide.
The company uses the latest technologies, including Direct PCR platform, double-column RNA isolation platform, and DNA-only silica membrane platform, to develop innovative solutions that simplify and accelerate molecular biology research and diagnosis.
Foregene's Direct PCR platform is a breakthrough technology that enables fast, highly-specific, and direct PCR from a wide range of human and animal whole blood samples. The novel buffer system replaces the need for complicated extraction or purification steps or use of additives. This technology is highly suitable for a wide range of applications, including PCR-based diagnosis of infectious diseases, genetic disorders, and cancer.
Foregene's double-column RNA isolation platform is a highly efficient and reliable tool for isolating high-quality RNA from a wide range of sources, including cells, tissues, and biofluids. This platform enables researchers and clinicians to obtain high-quality RNA in a fast and cost-effective manner, which is essential for accurate gene expression analysis, RNA sequencing, and other RNA-based applications.
Foregene's DNA-only silica membrane platform is a highly efficient and reliable tool for isolating high-quality DNA from a wide range of sources, including cells, tissues, and biofluids, such as blood, saliva, or urine. This platform enables researchers and clinicians to obtain high-quality DNA in a fast and cost-effective manner, which is essential for accurate genetic analysis, genotyping, and other DNA-based applications.
Foregene's IVD kits are designed to meet the needs of clinical laboratories and healthcare professionals who require accurate and reliable diagnostic solutions. The company offers a wide range of IVD kits for a variety of applications, including cancer diagnosis, infectious disease diagnosis, and genetic testing. The kits are designed to meet the highest quality standards and regulatory requirements, such as ISO 13485 and CE-IVD, and are easy to use, reliable, and cost-effective.
"We are committed to developing innovative solutions that simplify and accelerate molecular biology research and diagnosis," said Dr. Lee Jong-suk, CEO of Foregene Co., Ltd. "Our goal is to provide researchers and clinicians worldwide with the best possible tools to help them make accurate diagnoses, develop new treatments, and improve patient outcomes."
In conclusion, Foregene Co., Ltd. is a leading provider of innovative molecular biology lab reagents and IVD kits. The company is dedicated to developing cutting-edge solutions that meet the needs of researchers and clinicians worldwide. With its state-of-the-art technologies, including Direct PCR platform, double-column RNA isolation platform, and DNA-only silica membrane platform, Foregene is helping to simplify and accelerate molecular biology research and diagnosis, and improve patient outcomes.